A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells

Area of Science:

• Endocrinology
• Cell Biology
• Cancer Research

Background:

• Insulin-like growth factor-binding protein 3 (IGFBP-3) is known to modulate apoptosis in certain cancer cells.
• Previous studies indicated IGFBP-3 alone has no effect on cell death but modulates apoptosis in non-responsive cells.

Purpose of the Study:

• To investigate if a non-IGF binding mutant of IGFBP-3 retains intrinsic actions.
• To examine the effects of IGFBP-3 on apoptosis and cell growth in IGF-responsive and non-responsive breast cell lines.

Main Methods:

• Utilized Hs578T (IGF non-responsive), MCF-7 (IGF-responsive), and MCF-10A (normal breast epithelial) cell lines.
• Co-incubated cells with C2 (ceramide analogue) and various forms of IGFBP-3 (non-glycosylated, glycosylated, mutant).
• Assessed apoptosis and cell growth modulation by IGFBP-3.

Main Results:

• In Hs578T cells, all IGFBP-3 forms significantly accentuated C2-induced apoptosis.
• IGFBP-3 did not modulate C2-induced death in MCF-7 cells.
• In MCF-10A cells, IGFBP-3 acted as a survival factor and differentially affected cell growth (inhibition at low doses, stimulation at high doses), independent of IGF-1.

Conclusions:

• IGFBP-3 exhibits differential, IGF-1-independent effects on cell death and growth in normal and breast cancer cells.
• These findings highlight the complex, context-dependent roles of IGFBP-3 in breast cell biology.